Clinical Research

Tenaya Therapeutics could earn up to $1.1B for new heart disease research
Tenaya Therapeutics and Alnylam Pharmaceuticals have agreed to collaborate on identifying potential new gene therapies for the treatment of cardiovascular disease. Tenaya will receive an upfront payment of $10 million, but stands to earn much more.
High-sensitivity troponin protocol most successful at freestanding EDs
Freestanding EDs demonstrated meaningful operational advantages over hospitals when using an accelerated troponin pathway. This included earlier discharges for low-risk chest pain patients.
AI spots heart and lung conditions in eye images of premature infants
The AI model showcased an ability to accurately identify signs of pulmonary hypertension in retinal images. "This opens the possibility of using a simple photograph to gain insights into a premature infant's overall health," one researcher explained.
New AI-enabled heart failure implant shows early potential
The AI-powered Relief System is able to modulate venous pressure using hemodynamic data. The goal is to help patients better manage heart failure congestion at home.
AI helps identify risk in adults with congenital heart disease
STS plans on using new research out of Mayo Clinic to help with the development of a surgical risk calculator for adults with this challenging condition.

Do cancer treatments increase a patient's risk of cardiovascular disease?

Older cancer survivors appear to face higher risks of stroke, heart attack and heart failure. Early screening and preventative measures can help.

Post-mastectomy radiation therapy can be safely shortened prior to breast reconstruction

New research suggests that treatment regimens can be nearly halved without increasing the risk of recurrence or complications further down the road.

Medicare data stethoscope healthcare trends graphs finance financials

Cardiology groups cheer new bill that would improve access to Medicare claims data

If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation.

Focal pulsed field ablation (PFA) is a safe, effective treatment option for premature ventricular contractions (PVC), according to new data published in Circulation: Arrhythmia and Electrophysiology.[1]

PFA ablation safe, effective for treating premature ventricular contractions

Early data suggest PVC ablation with PFA technology is associated with a high success rate and minimal complications.

Long-term survival after valve-in-valve TAVR similar with self-expanding, balloon-expandable valves

Severe prosthesis-patient mismatch was more common with balloon-expandable valves, but that difference did not appear to impact outcomes.

Heart tissues within one of the Johns Hopkins space launch-ready chambers for study aboard the International Space Station. Photo from Jonathan Tsui.

Space travel disrupts normal rhythm in heart cells

Heart tissue samples that spent 30 days at the International Space Station appear to have been weakened by the low gravity conditions in space. This finding has implications for the heart health of astronauts.

Brain anatomy differs between people with opposing political ideologies

New research indicates that conservatives have larger amygdalas than their more progressive-leaning counterparts.

SAVR associated with several long-term benefits for patients with asymptomatic severe AS

The current evidence suggests early surgery is a better treatment option for asymptomatic severe AS than conservative care, researchers explained.

Clinical Research

Tenaya Therapeutics could earn up to $1.1B for new heart disease research

High-sensitivity troponin protocol most successful at freestanding EDs

AI spots heart and lung conditions in eye images of premature infants

New AI-enabled heart failure implant shows early potential

AI helps identify risk in adults with congenital heart disease